Abstract Number: 2206 • 2016 ACR/ARHP Annual Meeting
Data on Treatment from Brazilian Fibromyalgia Patients Registry (EpiFibro)
Background/Purpose: The Brazilian registry on fibromyalgia syndrome (EpiFibro) included 810 patients who satisfied the American College of Rheumatology Classification Criteria for Fibromyalgia (ACR1990) at the…Abstract Number: 44 • 2016 ACR/ARHP Annual Meeting
Ambroxol for Fibromyalgia. One-Group Pretest-Posttest Open Label Clinical Observation
Background/Purpose: A consistent line of investigation proposes that fibromyalgia is a sympathetically maintained neuropathic pain syndrome. Moreover it has been suggested that dorsal root ganglia…Abstract Number: 2217 • 2016 ACR/ARHP Annual Meeting
Adherence to Drug Therapy in Patients with Fibromyalgia
Background/Purpose: As in other chronic diseases, adherence to the treatment regimen of patients with fibromyalgia (FM) is low (between 30 and 80%), depending on the…Abstract Number: 48 • 2016 ACR/ARHP Annual Meeting
Fibromyalgia Impact Is a Potential Mediator for the Associations of Self-Efficacy and Pain Catastrophizing with Physical Functioning in Persons with Fibromyalgia
Background/Purpose: Fibromyalgia (FM) is a chronic multidimensional disorder that causes physical and psychological impairment, incurring significant healthcare costs. Self-efficacy and pain catastrophizing have been shown…Abstract Number: 2221 • 2016 ACR/ARHP Annual Meeting
Recognition of Secondary Fibromyalgia Using an Index of 3 Components of the Multi-Dimensional Health Assessment Questionnaire: 90% Agreement with ACR Criteria for Fibromyalgia
Background/Purpose: Secondary fibromyalgia (FM) is seen 15-20% of patients with rheumatoid arthritis (RA) (1), systemic lupus erythematosus (SLE) (2), osteoarthritis (OA), and other rheumatic diseases.…Abstract Number: 49 • 2016 ACR/ARHP Annual Meeting
Efficacy of Mirogabalin on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase 2 Proof-of-Concept Study
Background/Purpose: Mirogabalin is a novel, preferentially selective a2d-1 ligand intended for treatment of pain associated with fibromyalgia and neuropathic pain. Mirogabalin efficacy and safety was…Abstract Number: 2222 • 2016 ACR/ARHP Annual Meeting
Tai Chi Is More Effective Than Aerobic Exercise in Treating Fibromyalgia: A Randomized Controlled Trial
Background/Purpose: Fibromyalgia is a complex disorder with strong psychological and pain components and is best managed with multidisciplinary therapies. Previous studies have suggested that Tai…Abstract Number: 50 • 2016 ACR/ARHP Annual Meeting
Tai Chi Significantly Modulates Resting State Functional Connectivity of the Cognitive Control Network in Fibromyalgia
Background/Purpose: Fibromyalgia (FM) is a common and complex musculoskeletal pain syndrome with unsatisfactory treatment options. Studies suggest that Tai Chi mind-body exercise may be…Abstract Number: 2403 • 2016 ACR/ARHP Annual Meeting
Sleep Disruption in Children with Chronic Pain
Background/Purpose: Sleep disorders and fatigue are common in children with chronic pain syndromes, and contributes to psychosocial dysfunction, healthcare utilization, and school absences. We hypothesize…Abstract Number: 376 • 2016 ACR/ARHP Annual Meeting
Initial Validation of the Patient Reported Outcomes Measurement Information System Pediatric Pain Intensity Scale in Juvenile Idiopathic Arthritis, Juvenile Fibromyalgia and Sickle Cell Disease
Background/Purpose: The Patient Reported Outcomes Measurement Information System(PROMIS) is a publicly available assessment system offering multiple measures to assess physical, mental and social health.…Abstract Number: 994 • 2016 ACR/ARHP Annual Meeting
Validation Studies of the American College of Rheumatology (ACR) 2010 Fibromyalgia Diagnostic Criteria and the 2011 Self-Report Modification for Survey and Clinical Research
Background/Purpose: The provisional criteria of the American College of Rheumatology (ACR) 2010 and the 2011 self-report modification for survey and clinical research are widely used…Abstract Number: 996 • 2016 ACR/ARHP Annual Meeting
Use of a Shared Medical Appointment for Patients with Fibromyalgia in a Rural, Academic Medical Center: A Process Improvement Initiative for the Development of a New Care Model
Background/Purpose: Fibromyalgia is a complex chronic pain condition with patients often presenting with multiple somatic complaints that are difficult to address in standard new patient…Abstract Number: 997 • 2016 ACR/ARHP Annual Meeting
2016 Revisions to the 2010/2011 Fibromyalgia Diagnostic Criteria
Background/Purpose: The provisional criteria of the ACR 2010 and the 2011 self-report modification for survey and clinical research are valid, reliable and widely used for…Abstract Number: 998 • 2016 ACR/ARHP Annual Meeting
Brain Responses to Other’s Pain in Fibromyalgia – a Magnetoencephalography (MEG) Study
Background/Purpose: Fibromyalgia Syndrome (FMS) is a disorder characterized by the presence of widespread pain and tenderness, which is now believed to be, at least in…Abstract Number: 1058 • 2016 ACR/ARHP Annual Meeting
Adjustment Profiles Comprising Objective and Subjective Measures in Fibromyalgia Patients
Background/Purpose: Only one-third of FM patients obtain benefits after receiving one of the available therapy modalities. Insights into the heterogeneous picture of FM might improve…
- « Previous Page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- …
- 25
- Next Page »
